News

Relievant Medsystems — Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

Recent healthcare plan coverage of Intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients MARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. [...]

2023-11-20T12:09:39+00:00November 20th, 2023|All News, Company News|

VentureMed Receives Transitional Pass-through Payment (TPT) for FLEX Vessel PrepTM System

Minneapolis, Minnesota, November 8, 2023 - VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the Center for Medicare & Medicaid Services (CMS) has granted The [...]

2023-11-09T16:55:33+00:00November 9th, 2023|All News, Company News|

Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Gynesonics® Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that it has secured an incremental $42.5 million in financing (total of $67.2M inclusive of initial April 2023 financing). [...]

2023-11-02T14:28:22+00:00November 2nd, 2023|All News, Company News|

Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestone

REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately [...]

2023-10-18T11:06:33+01:00October 18th, 2023|All News, Company News|

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that [...]

2024-02-27T15:24:34+00:00September 19th, 2023|All News, Company News|

Virtual Incision Extends Series C Round with Additional $30M Funding

Investment will accelerate advancements of the MIRA Surgical System LINCOLN, Neb. – September 19, 2023 – Virtual Incision Corporation, the developer of the world’s first miniaturized robotic-assisted surgery (RAS) system, today announced a $30 million extension to its previous $46 million Series C financing. The round was led by current investors [...]

2023-09-19T17:00:12+01:00September 19th, 2023|All News, Company News|

The MIRA Surgical System Proceeds to FDA Substantive Review for Market Authorization Under the De Novo Classification Pathway

Virtual Incision Has Achieved a Significant Milestone in Its De Novo Request and is Closer to Potential Commercial Readiness  Lincoln, Neb. – May 18, 2023 – Virtual Incision Corporation today announced its De Novo request was submitted and is under substantive review by the U.S. Food and Drug Administration (FDA). [...]

2023-11-20T12:16:48+00:00May 18th, 2023|All News, Company News|

Relievant Medsystems Announces More Than 10,000 Patients Treated with the Intracept® Procedure for Vertebrogenic Low Back Pain

MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, today announced that more than 10,000 patients have been treated with the Intracept® Procedure. This is the latest in a series of milestone accomplishments as the [...]

2023-05-10T08:04:11+01:00May 9th, 2023|All News, Company News|

Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain

MINNEAPOLIS, April 19, 2023 (GLOBE NEWSWIRE) --  Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that it has completed the close of its $50 million Series G financing. The financing was led by [...]

2023-06-21T08:54:25+01:00April 19th, 2023|All News, Company News|
Go to Top